Megakaryocyte Features and bcr/abl Translocation in Chronic Myeloid Leukemia following Imatinib Mesylate (STI571) Therapy—a Fluorescence in-situ Hybridization Study

References

• Braziel, R.M., Launder, T.M., Druker, B.J., Olson, S.B., Magenis, R.E., Mauro, M.J., et al. (2002) "Hematopathologic and cytoge-netic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. PG-435-41", Blood, 100, 435–441.
   Google Scholar
• Talpaz, M., Silver, R.T., Druker, B.J., Goldman, J.M., Gambacorti-Passerini, C., Guilhot, F., et al. (2002) "Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study", Blood, 99, 1928 — 1937.
   Google Scholar
• Goldman, J.M. and Druker, B.J. (2001) "Chronic myeloid leukemia: current treatment options", Blood, 98, 2039–2042.
   Google Scholar
• Cervantes, F., Hernandez-Boluda, J.C., Steegmann, J.L., Conde, E., Alvarez-Larran, A., Lopez-Jimenez, J., et al. (2003) "Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients", Haematologica, 88, 1117–1122.
   Google Scholar
• Druker, B.J., Talpaz, M., Resta, Di., Peng, B., Buchdunger, E., Ford, J.M., et al. (2001) "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine lcinase in chronic myeloid leukemia", New England Journal of Medicine, 344, 1031 — 1037.
   Google Scholar
• Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., et al. (2002) "Hematologic and cytoge-netic responses to imatinib mesylate in chronic myelogenous leukemia", New England Journal of Medicine, 346, 645–652.
   Google Scholar
• O'Brien, S.G., Guilhot, F., Larson, R.A., Gathmann, I., Baccarani, M., Cervantes, F., et al. (2003) "Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia", New England Journal of Medicine, 348, 994 — 1004.
   Google Scholar
• Deininger, M.W. (2003) "Cytogenetic studies in patients on imatinib", Seminars in Hematology, 40, 50–55.
   Google Scholar
• Beham-Schmid, C., Apfelbeck, U., Sill, H., Tsybrovsky, 0., Hofler, G., Haas, 0.A., et al. (2002) "Treatment of chronic myelogenous leukemia with the tyrosine lcinase inhibitor STI571 results in marked regression of bone marrow fibrosis", Blood, 99, 381–383.
   Google Scholar
• Hasserjian, R.P., Boecklin, F., Parker, S., Chase, A., Dhar, S., Zaiac, M., et al. (2002) "ST1571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response", American Journal of Clinical Pathology, 117, 360–367.
   Google Scholar
• Rumpel, M., Friedrich, T. and Deininger, M.W. (2003) "Imatinib normalizes bone marrow vascularity in patients with chronic myeloid leukemia in first chronic phase", Blood, 101, 4641–4643.
   Google Scholar
• Frater, J.L., Tallman, M.S., Variakojis, D., Druker, B.J., Resta, D., Riley, MB., et al. (2003) "Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histo-pathology and correlation with genetic status", American Journal of Clinical Pathology, 119, 833–841.
   Google Scholar
• Bartl, R., Frisch, B. and Wilmanns, W. (1993) "Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD)", European Journal of Haematology, 50, 41— 52.
   Google Scholar
• Georgii, A., Buesche, G. and Kreft, A. (1998) "The histopathology of chronic myeloproliferative diseases", Baillieres Clinical Haema-tology, 11, 721–749.
   Google Scholar
• Nafe, R., Georgii, A., Kaloutsi, V., Fritsch, R.S. and Choritz, H. (1991) "Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders", Virchows Archive B, Cell Pathology Including Molecular Pathology, 61, I I I —116.
   Google Scholar
• Thiele, J., Titius, BR., Kopsidis, C. and Fischer, R. (1992) "Atypical micromegakaryocytes, promegakaryoblasts and mega-karyoblasts: a critical evaluation by immunohistochemistry, cyto-chemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes", Virchows Archive B, Cell Pathology Including Molecular Pathology, 62, 275— 282.
   Google Scholar
• Cordell, J.L., Falini, B., Erber, W.N., Ghosh, AK., Abdulaziz, Z., MacDonald, S., et al. (1984) "Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)", Journal of Histochemistry and Cytochemistry, 32, 219 — 229.
   Google Scholar
• Thiele, J. and Fischer, R. (1991) "Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview", Virchows Archive A, Pathological Anatomy and Histopathology, 418, 87–97.
   Google Scholar
• Kobzev, Y., Domracheva, E., Zakharova, A., Khoroshko, N., Turlcina, A. and Dewald, G. (1998) "Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia", Cancer Genetics and Cytogenetics, 106, 128— 134.
   Google Scholar
• Dewald, G.W., Wyatt, WA., Juneau, AL., Carlson, R.O., Zinsmeister, A.R., Jalal, S.M., et al. (1998) "Highly sensitive fluorescence in situ hybridization method to detect double BCR/ ABL fusion and monitor response to therapy in chronic myeloid leukemia", Blood, 91, 3357–3365.
   Google Scholar
• Nolte, M., Werner, M., Ewig, M., von Wasielewslci, R., Wilkens, L., Link, H., et al. (1996) "Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation", Leukemia and Lymphoma, 22, 287 — 294.
   Google Scholar
• Werner, M., Ewig, M., Nasarek, A., Wilkens, L., von Wasielewslci, R., Tchinda, J., et al. (1997) "Value of fluorescence in situ hybridization for detecting the bcr/abl gene fusion in interphase cells of routine bone marrow specimens", Diagnostic Molecular Pathology, 6, 282–287.
   Google Scholar
• Brynes, R.K., McCourty, A., Ho, J.P., Traweek, ST., Snyder, D.S. and Slovak, M.L. (1994) "Detection of the Philadelphia chromo-some in paraffin-embedded tissue by fluorescence in situ hybridiza-tion", Modern Pathology, 7, 565— 569.
   Google Scholar
• Thiele, J., Schmitz, B., Gross, H., Kvasnicka, H.M., Niederle, N., Leder, L.D., et al. (1997) "Fluorescence in-situ hybridization (FISH) reveals that in chronic myelogenous leukaemia (CML) following interferon-alpha therapy, normalization of megakaryo-cyte size is associated with the loss of bcr/abl translocation", Histopathology, 31, 215–221.
   Google Scholar
• Bentz, M., Cabot, G., Moos, M., Speicher, MR., Ganser, A., Lichter, P., et al. (1994) "Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization", Blood, 83, 1922— 1928.
   Google Scholar
• Dewald, G.W., Schad, CR., Christensen, ER., Tiede, AL., Zinsmeister, A.R., Spurbeck, J.L., et al. (1993) "The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL", Cancer Genetics and Cytogenetics, 71, 7 — 14.
   Google Scholar
• Amid, A., Yarkoni, S., Fejgin, M., Gaber, E., Nagler, A., Manor, Y., et al. (1993) "Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemia", Cancer Genetics and Cytogenetics, 65, 32— 34.
   Google Scholar